Therapeutic targeting of intestinal fibrosis in Crohn's disease

G Santacroce, MV Lenti, A Di Sabatino - Cells, 2022 - mdpi.com
Intestinal fibrosis is one of the most threatening complications of Crohn's disease. It occurs in
more than a third of patients with this condition, is associated with increased morbidity and …

Intestinal fibrosis

MV Lenti, A Di Sabatino - Molecular aspects of medicine, 2019 - Elsevier
Extensive tissue fibrosis is the end-stage process of a number of chronic conditions affecting
the gastrointestinal tract, including inflammatory bowel disease (Crohn's disease, ulcerative …

Imbalance of the renin–angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?

M Garg, SG Royce, C Tikellis, C Shallue, D Batu… - Gut, 2020 - gut.bmj.com
Objective We evaluated the influence of the renin–angiotensin system (RAS) on intestinal
inflammation and fibrosis. Design Cultured human colonic myofibroblast proliferation and …

The pathophysiological roles of the renin–angiotensin system in the gastrointestinal tract

M Garg, PW Angus, LM Burrell, C Herath… - Alimentary …, 2012 - Wiley Online Library
Background The renin‐angiotensin system (RAS) is a homeostatic pathway widely known to
regulate cardiovascular and renal physiology; however, little is known about its influence in …

Anti-inflammatory action of angiotensin 1-7 in experimental colitis

MA Khajah, MM Fateel, KV Ananthalakshmi… - PLoS …, 2016 - journals.plos.org
Background There is evidence to support a role for angiotensin (Ang) 1–7 in reducing the
activity of inflammatory signaling molecules such as MAPK, PKC and SRC. Enhanced …

The role of transforming growth factor (TGF)-β in modulating the immune response and fibrogenesis in the gut

P Biancheri, P Giuffrida, GH Docena… - Cytokine & growth factor …, 2014 - Elsevier
Transforming growth factor (TGF)-β, a pleiotropic cytokine released by both immune and non-
immune cells in the gut, exerts an important tolerogenic action by promoting regulatory T cell …

The potential therapeutic use of renin–angiotensin system inhibitors in the treatment of inflammatory diseases

R Ranjbar, M Shafiee, AR Hesari… - Journal of cellular …, 2019 - Wiley Online Library
Inflammation is a normal part of the immune response to injury or infection but its
dysregulation promotes the development of inflammatory diseases, which cause …

Mast cell tryptase promotes inflammatory bowel disease–induced intestinal fibrosis

B Liu, MQ Yang, TY Yu, YY Yin, Y Liu… - Inflammatory Bowel …, 2021 - academic.oup.com
Background Intestinal fibrosis is the final pathological outcome of chronic intestinal
inflammation without specific therapeutic drugs, which leads to ileus and surgical …

Upregulation of circulating components of the alternative renin-angiotensin system in inflammatory bowel disease: A pilot study

M Garg, LM Burrell, E Velkoska… - Journal of the Renin …, 2015 - journals.sagepub.com
Introduction: The relationship between intestinal inflammation and circulating components of
the renin-angiotensin system (RAS) is poorly understood. Materials and methods …

Role of transforming growth factor-β in inflammatory bowel disease and colitis-associated colon cancer

LA Feagins - Inflammatory bowel diseases, 2010 - academic.oup.com
Transforming growth factor-β (TGF-β) plays a central role in a wide array of cellular functions
including control of cell growth and differentiation, embryonic development, wound healing …